NDC 84549-101 – Diphenhydramine Hydrochloride
Diphenhydramine Hydrochloride 50 mg/mL · Injection, Solution · Intramuscular, Intravenous
Product NDC84549-101
Product details
- Brand name
- Diphenhydramine Hydrochloride
- Generic name
- Diphenhydramine Hydrochloride
- Labeler
- ProPharma Distribution
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA205723
- Marketed since
- May 1, 2019
- Listing expires
- December 31, 2026
- Pharmacologic class
- Histamine-1 Receptor Antagonist
Active ingredients
- Diphenhydramine Hydrochloride 50 mg/mL
Uses, dosage, side effects and warnings for Diphenhydramine hydrochloride →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 84549-101-25 | 1 mL in 1 VIAL, SINGLE-DOSE (84549-101-25) | Aug 27, 2025 |
Other Diphenhydramine hydrochloride products
- 72485-101 Diphenhydramine Hydrochloride 50 mg/mL · Injection, Solution · Armas Pharmaceuticals Inc.
- 55154-9363 Diphenhydramine Hydrochloride 50 mg/mL · Injection, Solution · Cardinal Health 107, LLC
- 76045-102 Diphenhydramine Hydrochloride 50 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 76045-235 Diphenhydramine Hydrochloride 50 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 51662-1374 Diphenhydramine Hydrochloride 50 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 51662-1348 Diphenhydramine Hydrochloride 50 mg/mL · Injection, Solution · HF Acquisition Co LLC, DBA HealthFirst
- 71872-7180 Diphenhydramine Hydrochloride 50 mg/mL · Injection, Solution · Medical Purchasing Solutions, LLC
- 25021-481 Diphenhydramine Hydrochloride 50 mg/mL · Injection, Solution · Sagent Pharmaceuticals
- 50090-0878 Diphenhydramine Hcl 50 mg/mL · Injection · A-S Medication Solutions
- 50090-1841 Diphenhydramine Hcl 50 mg/mL · Injection · A-S Medication Solutions
- 50090-7014 Diphenhydramine Hydrochloride 25 mg/1 · Capsule · A-S Medication Solutions
- 57344-091 Diphenhydramine Hydrochloride 25 mg/1 · Tablet, Coated · AAA Pharmaceutical, Inc.